Literature DB >> 11723635

Alternative psychotherapy approaches for social anxiety disorder.

J D Lipsitz1, R D Marshall.   

Abstract

Alternative therapies and therapy modalities for SAD are needed because: Established treatments (CBT and pharmacologic) do not help everyone who seeks help. Established treatments provide only partial decrease in symptoms for many patients. Patients may experience recurrence of symptoms in long-term follow-up. CBT does not reach enough patients in need. Alternative treatment approaches and modalities may also be needed to address the successful outcomes of CBT. Success in overcoming social anxiety symptoms can generate a whole new set of challenges. For example, a 31-year-old man who overcomes his fear of dating and begins his first romantic relationship may need a less symptomatically focused therapy to deal with issues that arise in this relationship. Likewise, a woman whose decreased social anxiety enables her to get a long-awaited promotion may need to deal with the stress of adjusting to her new responsibilities. An individual who overcomes phobia of public speaking and still has mild anxiety may need to graduate to a forum such as Toastmasters to provide continued exposure to further develop confidence and skills in public speaking.

Entities:  

Mesh:

Year:  2001        PMID: 11723635     DOI: 10.1016/s0193-953x(05)70265-3

Source DB:  PubMed          Journal:  Psychiatr Clin North Am        ISSN: 0193-953X


  2 in total

1.  A pilot study of clonazepam versus psychodynamic group therapy plus clonazepam in the treatment of generalized social anxiety disorder.

Authors:  Daniela Z Knijnik; Carlos Blanco; Giovanni Abrahão Salum; Carolina U Moraes; Clarissa Mombach; Ellen Almeida; Marília Pereira; Atahualpa Strapasson; Gisele G Manfro; Cláudio L Eizirik
Journal:  Eur Psychiatry       Date:  2008-09-06       Impact factor: 5.361

2.  Social anxiety disorder: radio electric asymmetric conveyor brain stimulation versus sertraline.

Authors:  Vania Fontani; Piero Mannu; Alessandro Castagna; Salvatore Rinaldi
Journal:  Patient Prefer Adherence       Date:  2011-11-22       Impact factor: 2.711

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.